Financials
Financial year 2026
Apotheek Bambrugge from Erpe-Mere, company number BE0661688963, closed financial year 2026 with a result of € 50,069 after tax. For that financial year Apotheek Bambrugge recorded a gross margin of € 236,256 and equity of € 336,219. Compared with financial year 2025, the result moved from € 41,299 to € 50,069. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 14, 2026.
€ 336,219
▼ 14% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 50,069
▲ 21% vs 2025
Profit after tax over the fiscal year.
€ 359,306
▲ 6% vs 2025
Cash and bank balances on the last day of the fiscal year.
€ 50,069 paid out
100 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2026
1.4
▼ 0.7 vs 2025
Average over the fiscal year, from the social balance sheet.
€ 118,395
▼ 14% vs 2025
€ 84,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 20,884
▼ 29% vs 2025
Book value of vehicles, furniture and equipment.
Debts at end 2026
€ 69,021
▼ 22% vs 2025
€ 18,369 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 54,908
▼ 8% vs 2025
Supplier invoices still open on the last day of the fiscal year.
€ 23,116
▼ 25% vs 2025
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Gross margin | € 284,423 | € 305,776 | € 250,612 | € 236,256 | ▼ 6% |
| Profit after taxes | € 53,027 | € 69,044 | € 41,299 | € 50,069 | ▲ 21% |
| Equity | € 278,903 | € 347,947 | € 389,245 | € 336,219 | ▼ 14% |
| Total debts | € 408,284 | € 381,868 | € 276,404 | € 356,020 | ▲ 29% |
| Cash | € 351,051 | € 316,652 | € 338,514 | € 359,306 | ▲ 6% |
| Retained profit | € 128,903 | € 197,947 | € 239,245 | € 186,219 | ▼ 22% |
| Dividend | € 0 | € 0 | € 0 | € 50,069 | |
| Bank debt | € 138,517 | € 109,279 | € 88,612 | € 69,021 | ▼ 22% |
| Balance sheet total | € 687,186 | € 729,815 | € 665,650 | € 692,238 | ▲ 4% |
| Employees (FTE) | 2 | 2 | 2.1 | 1.4 | ▼ 0.7 |
Key figures of Apotheek Bambrugge, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
What happened to Apotheek Bambrugge?
What happened at Apotheek Bambrugge in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: profit of € 50,069 (▲ 21% vs 2025). Source: NBB ↗
- New establishment in Erpe-Mere. KBO
- Start of the company according to the CBE. KBO
In short
From € 53,027 profit in 2023 to € 50,069 profit in 2026.
Paid € 97,472 in corporate taxes since 2023.
Best year ever: 2024, with € 69,044 profit.
On average € 168,800 of value added per employee in 2026.
A new publication or filing at Apotheek Bambrugge? We notify you, reason included.
Follow Apotheek BambruggeDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Apotheek Bambrugge is Magda Audenaert.
Directors
According to the 2026 annual accounts
Magda Audenaert
Director
Establishments
Establishment units
Physical locations of this company
Keerstraat 193
9420 Erpe-Mere
Oudenaardsesteenweg 547
9420 Erpe-Mere
Active since 24 August 2016
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
LEVEL27-AS * Please direct all complaints to [email protected] *, BE
Website info
Features
Security
Network
Details
- Company number
- 0661.688.963
- VAT number
- BE 0661.688.963
- Registered office
- Keerstraat 193, 9420 Erpe-Mere
- Names & denominations
- Apotheek Bambrugge
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 24 August 2016
- Peppol
- Active · Active since 19 Dec 2025
- Contact
- apotheekreservatie.be
- Activities · NACE
Detailhandel in farmaceutische producten
Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen
Lease van intellectuele eigendom en vergelijkbare producten, met uitzondering van werken onder auteursrecht
Verhuur en lease van andere huishoudelijke of persoonlijke artikelen, neg
Verhuur en lease van andere consumentenartikelen, n.e.g.